3 completed, 1 enrolling by invitation. 2 Phase 2, 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Enrolling by invitation 1 |
Follow Avmacol®: new trials by email Literature Review of Avmacol® trials Research Report on Avmacol®
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation Digital Bio-markers During Sulforaphane Treatment. Sulforaphane - Autism, Autism Spectrum Disorder | Not applicable | Enrolling by invitation | Rutgers, The State University of New Jersey | 10 | 2022-07-07 | 2025-10-30 |
| Clinical Trial of Lung Cancer Chemoprevention With Sulforaphane in Former Smokers Sulforaphane, Placebo - Lung Cancer | Phase 2 | Completed | Jian-Min Yuan, MD | 43 | 2018-01-25 | 2024-12-17 |
| Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer Avmacol® - HNSCC, Head and Neck Cancer | Early Phase 1 | Completed | University of Arizona | 6 | 2017-04-24 | 2021-06-21 |
| Sulforaphane to Reduce Symptoms of Schizophrenia Sulforaphane Nutraceutical, Identical-appearing Placebo - Schizophrenia, Schizoaffective Disorder | Phase 2 | Completed | Sheppard Pratt Health System | 64 | 2017-02-22 | 2021-07-27 |
Autism Spectrum Disorder (1) · Autistic Disorder (1) · Carcinoma in Situ (1) · Head and Neck Neoplasms (1) · Hyperplasia (1) · Lung Neoplasms (1) · Psychotic Disorders (1) · Schizophrenia (1) · Smoking Cessation (1) · Squamous Cell Carcinoma of Head and Neck (1)
Jian-Min Yuan, MD (1) · Rutgers, The State University of New Jersey (1) · Sheppard Pratt Health System (1) · University of Arizona (1)
United States (4)
Faith Dickerson, PhD, MPH (1) · Jian-Min Yuan, MD, PhD (1) · Julie E. Bauman, MD, MPH (1)
P50CA097190 (1), R01CA213123 (1)